MLM
45
-5
JNJ
41
3
NAVI
52
-2
DHR
32
-6
KHC
9
-4
WM
74
-5
WBA
43
-4
SO
57
6
AXP
67
-2
ROST
57
-3
ALLE
37
-4
SJM
9
-5
DE
42
3
HSIC
45
5
KMX
61
-3
HIG
66
2
FFIV
66
-4
PGR
59
-3
CCI
30
-11
LRCX
37
-9
MLM
45
-5
JNJ
41
3
NAVI
52
-2
DHR
32
-6
KHC
9
-4
WM
74
-5
WBA
43
-4
SO
57
6
AXP
67
-2
ROST
57
-3
ALLE
37
-4
SJM
9
-5
DE
42
3
HSIC
45
5
KMX
61
-3
HIG
66
2
FFIV
66
-4
PGR
59
-3
CCI
30
-11
LRCX
37
-9
Financhill
Back

First Trust Cnsmr Staples AlphaDEX® ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
36

FXG
First Trust Cnsmr Staples AlphaDEX® ETF

Last Price:
67.37
Seasonality Move:
2.59%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
36
First Trust Cnsmr Staples AlphaDEX® ETF (FXG) is a Sell

Is First Trust Cnsmr Staples AlphaDEX® ETF a Buy, Sell or Hold?

  • The current First Trust Cnsmr Staples AlphaDEX® ETF [FXG] share price is $67.22. The Score for FXG is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • FXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FXG Stock Price Chart

What is First Trust Cnsmr Staples AlphaDEX® ETF's stock price today?

  • The First Trust Cnsmr Staples AlphaDEX® ETF share price today is $67.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FXG is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FXG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 46.8 Sell
Chaikin Money Flow: -54348 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.6 - 68.2) Sell
Bollinger Bands (100): (65.51 - 68.15) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FXG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.16 Sell
20-day SMA: 67.3 Sell
50-day SMA: 67.51 Sell
200-day SMA: 66.35 Buy
8-day EMA: 67.87 Sell
20-day EMA: 67.59 Sell
50-day EMA: 67.39 Sell
200-day EMA: 66.11 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Trust Cnsmr Staples AlphaDEX® ETF Earnings Growth & FXG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Trust Cnsmr Staples AlphaDEX® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):